Johnson & Johnson

Founded in 1886, Johnson & Johnson is one of the oldest pharmaceutical companies in the country. Known for developing medical devices, pharmaceuticals, and consumer packaged goods, J&J is home to well-known products including Band-Aid bandages, Tylenol pain medications, Neutrogena skin and body products, and Acuvue contact lenses. Johnson & Johnson maintains operations in 60 countries, while its roughly 250 subsidiaries and their products are sold in more than 175 countries. During the coronavirus pandemic, Johnson & Johnson’s COVID-19 vaccine was the third to receive emergency use authorization from the U.S. Food and Drug Administration. Additionally, J&J’s vaccine was the first to be okayed in the U.S. that required only a single dose, and its administration into the arms of Americans significantly helped the country curb the spread of the virus and get back on a path to normalcy.
F500-2020-035-Johnson and Johnson
Justin Sullivan—Getty Images

Company Information

As of 6/5/23
Country
U.S.
Headquarters
New Brunswick, N.J.
Industry
Pharmaceuticals
CEO
Joaquin Duato
Company Type
Public
Ticker
JNJ
Revenues ($M)
$94,943
Profits ($M)
$17,941
Market Value ($M)
$483,576
Employees
152,700
Market value as of March 31, 2023.

America's Most Innovative Companies

Sector
Health Care
Culture rank
62
Process rank
83
Product rank
14

World's Most Admired Companies

Sector
Natural resources
Industry
Pharmaceuticals
Current All-Star Rank
22
Previous All-Star Rank
17
Industry Rank
1
Previous Industry Rank
1
Overall Score
7.88
Innovation
3
People Management
1
Use of Corporate Assets
1
Social Responsibility
3
Quality of Management
1
Financial Soundness
1
Long-Term Investment Value
1
Quality of Products/Services
4
Global Competitiveness
1

Key Financials (Last Fiscal Year)

$ millions
% change
Revenues ($M)
$93,775
13.6%
Profits ($M)
$20,878
41.9%
Assets ($M)
$182,018
-
Total Stockholder Equity ($M)
$74,023
-

Profit Ratios

Profit as % of Revenues
22.3%
Profits as % of Assets
11.5%
Profits as % of Stockholder Equity
28.2%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)
7.81
EPS % Change (from 2020)
41.7%
EPS % Change (5 year annual rate)
5.7%
EPS % Change (10 year annual rate)
8.4%

Total Return

Total Return to Investors (2021)
11.5%
Total Return to Investors (5 year, annualized)
11.1%
Total Return to Investors (10 year, annualized)
13.2%
Lists ranking Johnson & Johnson
RANK37
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MORE
RANK107
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE
RANK22
World's Most Admired Companies - 2023The 25th Fortune World’s Most Admired Companies li...READ MORE
RANK13
America's Most Innovative Companies - 2023The 300 companies on this list are transforming in...READ MORE